Fluorine in PDB 5ar8: RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
Enzymatic activity of RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
All present enzymatic activity of RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide:
2.7.10.2;
2.7.11.1;
Protein crystallography data
The structure of RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide, PDB code: 5ar8
was solved by
A.K.Charnley,
M.A.Convery,
A.Lakdawala Shah,
E.Jones,
P.Hardwicke,
A.Bridges,
B.J.Votta,
P.J.Gough,
R.W.Marquis,
J.Bertin,
L.Casillas,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
33.68 /
2.79
|
Space group
|
P 32 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
132.371,
132.371,
107.424,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
20.31 /
23.27
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
(pdb code 5ar8). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide, PDB code: 5ar8:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 5ar8
Go back to
Fluorine Binding Sites List in 5ar8
Fluorine binding site 1 out
of 4 in the RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1311
b:95.9
occ:1.00
|
F33
|
A:XYW1311
|
0.0
|
95.9
|
1.0
|
C32
|
A:XYW1311
|
1.3
|
94.5
|
1.0
|
C34
|
A:XYW1311
|
2.3
|
93.7
|
1.0
|
C31
|
A:XYW1311
|
2.4
|
90.8
|
1.0
|
O29
|
A:XYW1311
|
2.6
|
86.0
|
1.0
|
S28
|
A:XYW1311
|
3.0
|
84.6
|
1.0
|
CG2
|
A:ILE93
|
3.3
|
93.4
|
1.0
|
C37
|
A:XYW1311
|
3.6
|
90.7
|
1.0
|
C35
|
A:XYW1311
|
3.6
|
91.5
|
1.0
|
CD1
|
A:LEU70
|
3.7
|
0.8
|
1.0
|
C25
|
A:XYW1311
|
3.8
|
67.7
|
1.0
|
CB
|
A:ILE93
|
3.9
|
92.3
|
1.0
|
O30
|
A:XYW1311
|
4.1
|
83.6
|
1.0
|
C36
|
A:XYW1311
|
4.1
|
89.9
|
1.0
|
N27
|
A:XYW1311
|
4.1
|
76.2
|
1.0
|
CD1
|
A:ILE93
|
4.1
|
0.3
|
1.0
|
CG1
|
A:ILE93
|
4.3
|
92.6
|
1.0
|
C26
|
A:XYW1311
|
4.4
|
69.6
|
1.0
|
CG2
|
A:THR95
|
4.5
|
65.5
|
1.0
|
F38
|
A:XYW1311
|
4.7
|
92.0
|
1.0
|
C24
|
A:XYW1311
|
4.9
|
63.3
|
1.0
|
CG
|
A:LEU70
|
5.0
|
0.6
|
1.0
|
CD1
|
A:ILE81
|
5.0
|
92.2
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 5ar8
Go back to
Fluorine Binding Sites List in 5ar8
Fluorine binding site 2 out
of 4 in the RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1311
b:92.0
occ:1.00
|
F38
|
A:XYW1311
|
0.0
|
92.0
|
1.0
|
C37
|
A:XYW1311
|
1.3
|
90.7
|
1.0
|
C31
|
A:XYW1311
|
2.3
|
90.8
|
1.0
|
C36
|
A:XYW1311
|
2.3
|
89.9
|
1.0
|
O30
|
A:XYW1311
|
2.9
|
83.6
|
1.0
|
S28
|
A:XYW1311
|
3.0
|
84.6
|
1.0
|
CE2
|
A:PHE165
|
3.1
|
85.0
|
1.0
|
CA
|
A:ALA163
|
3.2
|
61.8
|
1.0
|
N27
|
A:XYW1311
|
3.2
|
76.2
|
1.0
|
C32
|
A:XYW1311
|
3.6
|
94.5
|
1.0
|
C35
|
A:XYW1311
|
3.6
|
91.5
|
1.0
|
N
|
A:ASP164
|
3.6
|
68.1
|
1.0
|
CD2
|
A:PHE165
|
3.6
|
82.2
|
1.0
|
CB
|
A:ALA163
|
3.7
|
62.1
|
1.0
|
C
|
A:ALA163
|
3.8
|
69.4
|
1.0
|
O
|
A:ILE162
|
3.9
|
59.4
|
1.0
|
CZ
|
A:PHE165
|
4.0
|
82.4
|
1.0
|
CB
|
A:LEU79
|
4.0
|
55.8
|
1.0
|
C34
|
A:XYW1311
|
4.1
|
93.7
|
1.0
|
C26
|
A:XYW1311
|
4.2
|
69.6
|
1.0
|
N
|
A:ALA163
|
4.3
|
61.8
|
1.0
|
CD2
|
A:LEU79
|
4.4
|
61.1
|
1.0
|
O29
|
A:XYW1311
|
4.4
|
86.0
|
1.0
|
C
|
A:ILE162
|
4.5
|
61.9
|
1.0
|
O
|
A:LEU79
|
4.7
|
64.1
|
1.0
|
F33
|
A:XYW1311
|
4.7
|
95.9
|
1.0
|
C25
|
A:XYW1311
|
4.7
|
67.7
|
1.0
|
CG
|
A:LEU79
|
4.8
|
59.6
|
1.0
|
N
|
A:LEU79
|
4.8
|
55.8
|
1.0
|
CG
|
A:PHE165
|
4.8
|
78.7
|
1.0
|
CA
|
A:ASP164
|
4.8
|
67.5
|
1.0
|
CA
|
A:LEU79
|
4.9
|
56.0
|
1.0
|
CD1
|
A:LEU70
|
5.0
|
0.8
|
1.0
|
N
|
A:PHE165
|
5.0
|
63.1
|
1.0
|
O
|
A:ALA163
|
5.0
|
69.0
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 5ar8
Go back to
Fluorine Binding Sites List in 5ar8
Fluorine binding site 3 out
of 4 in the RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1311
b:93.0
occ:1.00
|
F33
|
B:XYW1311
|
0.0
|
93.0
|
1.0
|
C32
|
B:XYW1311
|
1.3
|
93.4
|
1.0
|
C34
|
B:XYW1311
|
2.3
|
94.9
|
1.0
|
C31
|
B:XYW1311
|
2.4
|
89.6
|
1.0
|
O29
|
B:XYW1311
|
2.6
|
84.5
|
1.0
|
S28
|
B:XYW1311
|
3.0
|
82.7
|
1.0
|
CG2
|
B:ILE93
|
3.2
|
83.8
|
1.0
|
CD1
|
B:ILE93
|
3.5
|
95.4
|
1.0
|
C35
|
B:XYW1311
|
3.6
|
94.3
|
1.0
|
C37
|
B:XYW1311
|
3.6
|
91.4
|
1.0
|
CD1
|
B:LEU70
|
3.7
|
0.8
|
1.0
|
CB
|
B:ILE93
|
3.9
|
84.2
|
1.0
|
C25
|
B:XYW1311
|
4.0
|
57.1
|
1.0
|
O30
|
B:XYW1311
|
4.0
|
83.2
|
1.0
|
CG1
|
B:ILE93
|
4.1
|
84.8
|
1.0
|
C36
|
B:XYW1311
|
4.1
|
93.5
|
1.0
|
N27
|
B:XYW1311
|
4.2
|
73.5
|
1.0
|
C26
|
B:XYW1311
|
4.6
|
62.8
|
1.0
|
CD1
|
B:ILE81
|
4.6
|
77.8
|
1.0
|
F38
|
B:XYW1311
|
4.7
|
91.7
|
1.0
|
CG2
|
B:THR95
|
4.8
|
60.0
|
1.0
|
CG
|
B:LEU70
|
5.0
|
0.4
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 5ar8
Go back to
Fluorine Binding Sites List in 5ar8
Fluorine binding site 4 out
of 4 in the RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of RIP2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1311
b:91.7
occ:1.00
|
F38
|
B:XYW1311
|
0.0
|
91.7
|
1.0
|
C37
|
B:XYW1311
|
1.3
|
91.4
|
1.0
|
C31
|
B:XYW1311
|
2.3
|
89.6
|
1.0
|
C36
|
B:XYW1311
|
2.3
|
93.5
|
1.0
|
S28
|
B:XYW1311
|
3.0
|
82.7
|
1.0
|
N27
|
B:XYW1311
|
3.0
|
73.5
|
1.0
|
O30
|
B:XYW1311
|
3.0
|
83.2
|
1.0
|
CE1
|
B:PHE165
|
3.2
|
83.2
|
1.0
|
CA
|
B:ALA163
|
3.2
|
64.2
|
1.0
|
CD1
|
B:PHE165
|
3.3
|
83.2
|
1.0
|
N
|
B:ASP164
|
3.5
|
73.5
|
1.0
|
C32
|
B:XYW1311
|
3.6
|
93.4
|
1.0
|
C35
|
B:XYW1311
|
3.6
|
94.3
|
1.0
|
C
|
B:ALA163
|
3.7
|
73.6
|
1.0
|
CB
|
B:ALA163
|
3.8
|
64.5
|
1.0
|
C26
|
B:XYW1311
|
4.0
|
62.8
|
1.0
|
O
|
B:ILE162
|
4.0
|
59.6
|
1.0
|
C34
|
B:XYW1311
|
4.1
|
94.9
|
1.0
|
CB
|
B:LEU79
|
4.3
|
58.1
|
1.0
|
O29
|
B:XYW1311
|
4.4
|
84.5
|
1.0
|
N
|
B:ALA163
|
4.4
|
62.4
|
1.0
|
CZ
|
B:PHE165
|
4.5
|
81.6
|
1.0
|
CD2
|
B:LEU79
|
4.5
|
59.3
|
1.0
|
C25
|
B:XYW1311
|
4.6
|
57.1
|
1.0
|
CA
|
B:ASP164
|
4.6
|
74.2
|
1.0
|
C
|
B:ILE162
|
4.6
|
61.8
|
1.0
|
CG
|
B:PHE165
|
4.7
|
80.4
|
1.0
|
N
|
B:PHE165
|
4.7
|
76.9
|
1.0
|
F33
|
B:XYW1311
|
4.7
|
93.0
|
1.0
|
O
|
B:LEU79
|
4.7
|
62.5
|
1.0
|
O
|
B:ALA163
|
4.8
|
73.0
|
1.0
|
C39
|
B:XYW1311
|
4.8
|
57.6
|
1.0
|
CD1
|
B:LEU70
|
4.9
|
0.8
|
1.0
|
CG
|
B:LEU79
|
4.9
|
60.1
|
1.0
|
|
Reference:
A.K.Charnley,
M.A.Convery,
A.Lakdawala Shah,
E.Jones,
P.Hardwicke,
A.Bridges,
M.Ouellette,
R.Totoritis,
B.Schwartz,
B.W.King,
D.D.Wisnoski,
J.Kang,
P.M.Eidam,
B.J.Votta,
P.J.Gough,
R.W.Marquis,
J.Bertin,
L.Casillas.
Crystal Structures of Human RIP2 Kinase Catalytic Domain Complexed with Atp-Competitive Inhibitors: Foundations For Understanding Inhibitor Selectivity. Bioorg.Med.Chem. V. 23 7000 2015.
ISSN: ISSN 0968-0896
PubMed: 26455654
DOI: 10.1016/J.BMC.2015.09.038
Page generated: Thu Aug 1 07:50:21 2024
|